Drug: Bevacizumab Injury: Hypertension Quarter: 2016Q3
Total Records: 97 Number of Pages: 5
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 126024662 | Bevacizumab | Hypertension | CIPLA | 0.00 | 0 | 20160812 | GB | |
| 126056582 | Bevacizumab | Hypertension | ROCHE | 0.00 | M | 92 KG | 20160816 | CA |
| 126066891 | BEVACIZUMAB | Hypertension | RANBAXY | 57.00 YR | M | 0 | 20160729 | GB |
| 126096861 | Bevacizumab | Hypertension | ROCHE | 0.00 | 0 | 20160801 | CN | |
| 126128401 | Bevacizumab | Hypertension | ROCHE | 0.00 | 0 | 20160802 | US | |
| 126128551 | Bevacizumab | Hypertension | ROCHE | 0.00 | 0 | 20160802 | US | |
| 126134182 | BEVACIZUMAB | Hypertension | GLENMARK | 0.00 | 0 | 20160809 | COUNTRY NOT SPECIFIED | |
| 126230182 | BEVACIZUMAB | Hypertension | FRESENIUS KABI | 57.00 YR | M | 0 | 20160810 | GB |
| 126251631 | BEVACIZUMAB | Hypertension | JANSSEN | 0.00 | F | 0 | 20160805 | US |
| 126267892 | BEVACIZUMAB | Hypertension | AMGEN | 0.00 | F | 0 | 20160812 | US |
| 126338831 | BEVACIZUMAB | Hypertension | PFIZER | 57.00 YR | M | 0 | 20160809 | GB |
| 126403931 | BEVACIZUMAB | Hypertension | AUROBINDO | 57.00 YR | M | 0 | 20160810 | GB |
| 126419731 | BEVACIZUMAB | Hypertension | MYLAN | 0.00 | 0 | 20160810 | GB | |
| 126467511 | BEVACIZUMAB | Hypertension | RANBAXY | 57.00 YR | M | 0 | 20160812 | GB |
| 126586681 | Bevacizumab | Hypertension | ROCHE | 78.00 YR | M | 0 | 20160817 | DE |
| 126626232 | Bevacizumab | Hypertension | ROCHE | 0.00 | F | 0 | 20160912 | CN |
| 126629832 | Bevacizumab | Hypertension | ROCHE | 74.69 YR | F | 59 KG | 20160920 | BE |
| 126665311 | Bevacizumab | Hypertension | ROCHE | 74.44 YR | M | 0 | 20160819 | BE |
| 126759101 | Bevacizumab | Hypertension | ROCHE | 63.00 YR | M | 0 | 20160823 | FR |
| 126838491 | Bevacizumab | Hypertension | ROCHE | 0.00 | 0 | 20160825 | ES |
Total Records: 97 Number of Pages: 5